Skip to main content
. 2017 Feb 6;12(2):e0171328. doi: 10.1371/journal.pone.0171328

Fig 6. Effect of reducing agents on SRPK1 cysteine mutants electrophoretic mobility.

Fig 6

Lysates from 293T cells transfected with wild-type SRPK1 and its mutant forms were analyzed under non-reducing conditions (i.e., without DTT) or reducing conditions (in the presence of 90 mM DTT) on 10% SDS-polyacrylamide gels. The proteins were then transferred to nitrocellulose and epitope-tagged wild-type or mutant SRPK1 was detected with the M5 anti-FLAG monoclonal antibody.